For most people focused primarily on weight loss (which is the majority of the GLP-1 user population), tirzepatide is the stronger option based on current evidence
Liu J, Yin J, Chen P, Liu D, He W, Li Y, et al
Clinical trials show that patients on semaglutide lose an average of 35 pounds over 68 weeks, while tirzepatide users achieve 22-26% body weight reduction in the ZEPBOUND trials
At Boca Medical Care, we are committed to promoting holistic health and wellness, understanding that effective weight management goes beyond targeted exercises
Combining medications can be complicated, as it requires understanding how each drug works in the body and whether they could interact with each other
10.1074/jbc.272.46.28869 [DOI] [PubMed] [Google Scholar] Zhang J., Ferguson S